Outcome of primary percutaneous intervention in patients with infarct-related coronary artery ectasia

Ismail Erden1, Emine Cakcak Erden, Hakan Ozhan

  • 1Department of Cardiology, Duzce University, Turkey. iserdemus@yahoo.com

Angiology
|April 17, 2010
PubMed

Insights

Ectasia in the infarct-related artery (EIRA) is linked to worse outcomes in acute myocardial infarction (AMI) patients undergoing primary percutaneous coronary intervention (pPCI). EIRA predicts adverse clinical events, highlighting its significance in AMI management.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Limited data exists on acute myocardial infarction (AMI) outcomes in patients with coronary artery ectasia (CAE).
  • Assessing the clinical impact of infarct-related artery ectasia (EIRA) in AMI patients is crucial.

Purpose of the Study:

  • To determine if EIRA is associated with adverse clinical outcomes in AMI patients treated with primary percutaneous coronary intervention (pPCI).

Main Methods:

  • Retrospective analysis of 643 consecutive AMI patients treated with pPCI.
  • Comparison of clinical characteristics and procedural outcomes between patients with and without EIRA.

Main Results:

  • EIRA was present in 4.8% of patients, predominantly in the right coronary artery (RCA).
  • Patients with EIRA were younger and had higher rates of hypertension, stroke, smoking, inferior AMI, and higher Killip scores.
  • EIRA was associated with impaired epicardial flow, higher thrombus burden, worse myocardial perfusion, and more distal embolization.
  • Lower ST-segment resolution and collateralization were observed in patients with EIRA.
  • EIRA independently predicted adverse outcomes (OR: 0.197; 95% CI: 0.062-0.633; P = .006).

Conclusions:

  • Infarct-related artery ectasia is an independent predictor of adverse clinical outcomes in AMI patients undergoing pPCI.
  • EIRA is associated with poorer procedural results and increased risk of adverse events.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...